Bank Of Montreal Talaris Therapeutics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$2.68 - $3.22 $530 - $637	-198 Reduced 1.56%	12,500 $35,000
Q2 2023 Aug 02, 2023	BUY	$1.78 - $3.2 $22,602 - $40,633	12,698 New	12,698 $38,000
Q1 2023 Jun 13, 2024	BUY	$1.09 - $2.09 $17,399 - $33,362	15,963 New	15,963 $30,000
Q3 2022 Nov 10, 2022	BUY	$2.3 - $5.03 $716,723 - $1.57 Million	311,619 Added 1388.55%	334,061 $1.19 Million
Q2 2022 Aug 11, 2022	BUY	$4.51 - $9.85 $101,213 - $221,053	22,442 New	22,442 $203,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.